AR037565A1 - Formas de sales de amlodipina y procedimientos para prepararlas. - Google Patents

Formas de sales de amlodipina y procedimientos para prepararlas.

Info

Publication number
AR037565A1
AR037565A1 ARP020104445A ARP020104445A AR037565A1 AR 037565 A1 AR037565 A1 AR 037565A1 AR P020104445 A ARP020104445 A AR P020104445A AR P020104445 A ARP020104445 A AR P020104445A AR 037565 A1 AR037565 A1 AR 037565A1
Authority
AR
Argentina
Prior art keywords
forms
procedures
prepare
amlodipine besylate
amlodipine salts
Prior art date
Application number
ARP020104445A
Other languages
English (en)
Inventor
Gerrit J B Ettema
Hans J Hoorn
Jacobus M Lemmens
Original Assignee
Synthon Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthon Bv filed Critical Synthon Bv
Publication of AR037565A1 publication Critical patent/AR037565A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se describen formas de besilato de amlodipina, que incluyen hidratos de besilato de amlodipina y novedosos anhidratos de besilato de amlodipina. Se describen un método para preparar diversas formas de besilato de amlodipina a partir de un medio acuoso así como el uso de las mismas como bloqueadores de canales de calcio.
ARP020104445A 2001-11-21 2002-11-20 Formas de sales de amlodipina y procedimientos para prepararlas. AR037565A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33174201P 2001-11-21 2001-11-21

Publications (1)

Publication Number Publication Date
AR037565A1 true AR037565A1 (es) 2004-11-17

Family

ID=23295188

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020104445A AR037565A1 (es) 2001-11-21 2002-11-20 Formas de sales de amlodipina y procedimientos para prepararlas.

Country Status (5)

Country Link
US (1) US6828339B2 (es)
EP (1) EP1448197A1 (es)
AR (1) AR037565A1 (es)
AU (1) AU2002343257A1 (es)
WO (1) WO2003043635A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1152013C (zh) * 2001-11-22 2004-06-02 张喜田 一类左旋氨氯地平盐的水合物及其制剂
US20070135488A1 (en) * 2002-04-13 2007-06-14 Chung You S Amlodipine nicotinate and process for the preparation thereof
AU2003260984A1 (en) * 2002-09-11 2004-04-30 Hanlim Pharmaceutical Co., Ltd. S-(-)-amlodipine nicotinate and process for the preparation thereof
KR100558505B1 (ko) * 2003-01-27 2006-03-07 한미약품 주식회사 안정한 무정형 암로디핀 캠실레이트, 이의 제조방법 및이를 포함하는 경구투여용 조성물
JP4509118B2 (ja) * 2004-10-06 2010-07-21 エルメッド エーザイ株式会社 医薬組成物及びその製造方法、並びに医薬組成物におけるジヒドロピリジン系化合物の安定化方法
CN103083318A (zh) * 2004-11-05 2013-05-08 贝林格尔.英格海姆国际有限公司 包含替米沙坦和氨氯地平的双层片剂
WO2006059217A1 (en) * 2004-12-01 2006-06-08 Ranbaxy Laboratories Limited Stable solid dosage forms of amlodipine besylate and processes for their preparation
AU2006224161A1 (en) * 2005-03-15 2006-09-21 Lupin Limited Pharmaceutical compositions of amlodipine and benazepril
WO2006118210A1 (ja) * 2005-04-28 2006-11-09 Eisai R & D Management Co., Ltd. ジヒドロピリジン系化合物の分解を防止する方法
GT200600371A (es) * 2005-08-17 2007-03-21 Formas de dosis sólidas de valsartan y amlodipina y método para hacer las mismas
FR2894826B1 (fr) * 2005-12-21 2010-10-22 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent
CN102037091B (zh) 2008-03-20 2014-09-03 艾利丹尼森公司 具有官能团的控制位置的丙烯酸聚合物
PL2571906T3 (pl) 2010-05-19 2015-02-27 Avery Dennison Corp Uporządkowana architektura w polimerach akrylowych
EP2766404B1 (en) 2011-10-14 2019-11-13 Avery Dennison Corporation Controlled architecture polymers
CN104326970B (zh) * 2014-09-09 2016-04-13 石药集团欧意药业有限公司 左旋氨氯地平马来酸盐化合物及制备方法与含其药物制剂
CN110882249B (zh) 2019-11-08 2021-04-30 北京吾为尔创科技有限公司 含苯磺酸左氨氯地平水合物的组合物及其制备方法
CN119367310B (zh) * 2024-12-27 2025-04-18 成都硕德药业有限公司 一种比索洛尔氨氯地平复方片剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8608335D0 (en) * 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
SI9200344B (sl) * 1992-11-26 1998-06-30 Lek, Postopek za pripravo amlodipin benzensulfonata
HU221810B1 (hu) * 1997-08-12 2003-01-28 EGIS Gyógyszergyár Rt. Eljárás amlodipin-bezilát előállítására és az eljárás intermedierjei
PL189666B1 (pl) * 1998-04-09 2005-09-30 Adamed Sp Z Oo Sposób otrzymywania benzenosulfonianu amlodypiny
UA72768C2 (en) * 1999-07-05 2005-04-15 Richter Gedeon Vegyeszet A method for obtaining amilodipine benzenesulphonate
AU2001294354A1 (en) * 2000-12-29 2002-07-16 Bioorganics B.V. Process for making amlodipine, derivatives thereof, and precursors therefor
SI21233A (sl) 2002-05-31 2003-12-31 LEK, tovarna farmacevtskih in kemičnih izdelkov, d.d. Kristalni hidratni obliki amlodipin benzensulfonata visoke čistote, postopki za njuno pripravo in uporaba

Also Published As

Publication number Publication date
US6828339B2 (en) 2004-12-07
WO2003043635A1 (en) 2003-05-30
US20030139455A1 (en) 2003-07-24
AU2002343257A1 (en) 2003-06-10
EP1448197A1 (en) 2004-08-25

Similar Documents

Publication Publication Date Title
AR037565A1 (es) Formas de sales de amlodipina y procedimientos para prepararlas.
UY27748A1 (es) Derivados de quinolina e isoquinolina, un método para su obtención y su uso como inhibidores de la inflamación.
CR7728A (es) Nuevas quinazolinas espirocondensadas y su uso como inhibidores de la fosfodiesterasa
UY27571A1 (es) 2-tio-3, 5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
UY27381A1 (es) 2-tio-3,5-diciano-4-fenil-6-aminopiridinas sustituidas y su uso
AR066694A2 (es) Metodo para la preparacion de citalopram
EA201000496A1 (ru) Замещенное соединение миноциклина, способ получения замещенных соединений миноциклина (варианты)
EA200400252A1 (ru) Стабильная полиморфная модификация флибансерина, способ её промышленного получения и её применение для получения лекарственных средств
BRPI0414539B8 (pt) composto, composição farmacêutica, e, uso de um composto
NO20035848L (no) Nye vevsfaktorrettede antistoffer som antikoagulanter
CR7583A (es) Nueva sal formiato de o-desmetil venlafaxina
DK1668001T3 (da) Substituerede heteroarylbenzofuransyrer
DK1309672T3 (da) Fremgangsmåde til fremstilling af infektiös reovirus
BG111461A (en) TECHNICAL METHOD FOR OBTAINING TROPENOL
CR8358A (es) Pentalones transpuestos, un metodo para prepararlos y su uso como antiinflamatorios
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EA200401428A1 (ru) Способ получения цефдинира
BR0207119B1 (pt) processo para produzir microcápsulas azuis, e uso das mesmas.
CY1108121T1 (el) Διαδικασια παρασκευης ζ-φλουπεντιξολης
AR028743A1 (es) DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA
ECSP034532A (es) Derivados del 1-aminobutan-3-ol sustituido
HN2001000021A (es) Nuevos derivados de amidas heterociclicas
BRPI0514975A (pt) processo para produzir trietanolamina, e, trietanolamina
EA200400876A1 (ru) Способ получения производных толуола

Legal Events

Date Code Title Description
FA Abandonment or withdrawal